ATC Group: N02AE Oripavine derivatives

The World Health Organization's ATC classification organizes medical drugs based on therapeutic properties, chemical composition, and anatomy. It helps make essential medicines readily available globally and is widely used in the pharmaceutical industry.

Position of N02AE in the ATC hierarchy

Level Code Title
1 N Nervous system
2 N02 Analgesics
3 N02A Opioids
4 N02AE Oripavine derivatives

Group N02AE contents

Code Title
N02AE01 Buprenorphine

Active ingredients in N02AE

Active Ingredient Description
Buprenorphine

Buprenorphine is an opioid partial agonist/antagonist which attaches itself to the ÎŒ (mu) and Îș (kappa) receptors of the brain. Its activity in opioid maintenance treatment is attributed to its slowly reversible link with the ÎŒ receptors which, over a prolonged period, minimises the need of illicit opioids for patients with opioid dependence.

Related product monographs

Title Information Source Document Type  
BUTEC Transdermal patch Medicines & Healthcare Products Regulatory Agency (GB) MPI, EU: SmPC
BUTRANS Transdermal system FDA, National Drug Code (US) MPI, US: SPL/PLR
NORSPAN Patch Medicines and Medical Devices Safety Authority (NZ) MPI, EU: SmPC
RELETRANS Transdermal patch Medicines & Healthcare Products Regulatory Agency (GB) MPI, EU: SmPC
SUBOXONE Sublingual tablet European Medicines Agency (EU) MPI, EU: SmPC
TEMGESIC Solution for injection Medicines & Healthcare Products Regulatory Agency (GB) MPI, EU: SmPC
TEMGESIC Sublingual tablet Medicines & Healthcare Products Regulatory Agency (GB) MPI, EU: SmPC
TRANSTEC Transdermal patch Medicines & Healthcare Products Regulatory Agency (GB) MPI, EU: SmPC